CROs raise the alarm as clients de­lay R&D plans over fund­ing, tar­iff wor­ries

Con­tract re­search or­ga­ni­za­tions Icon and Med­pace have both re­port­ed high rates of can­celed or de­layed R&D projects on the back of the Trump ad­min­is­tra­tion’s fund­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER